Due to the complex nature, of molecule discovery and development, it is widely acknowledged as one of the most financially risky endeavors for the pharmaceutical industry. Much of this cost comes from failures, which account for 75 percent of the total research and development costs.

As part of the molecule discovery process and with ever-expanding compound libraries, it has become necessary to ensure sample integrity.

Malvern's high throughput aggregation screening tools enable compound library integrity management, enabling scientists to make better decisions at every step, resulting in more cost-effective, efficient and predictive molecule discovery process.